Clinical Trial Update: Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an anti-NKG2A monoclonal antibody in Acute Myeloid Leukemia or Myelodysplastic Syndromes patients undergoing haploidentical tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• Anti-NKG2A Monoclonal Antibody (anti-NKG2A monoclonal antibody)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Acute Myeloid Leukaemia, MDS (Myelodysplastic Syndrome) | Phase 2 | Status: RECRUITING